home / stock / rvmd / rvmd articles

RVMD Articles, Revolution Medicines Inc. - From 04/10/24

Stock Information
Company Name: Revolution Medicines Inc.
Stock Symbol: RVMD
Market: NASDAQ
Website: revmed.com
Menu
RVMD RVMD Quote RVMD Short RVMD News RVMD Articles RVMD Message Board
Get RVMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. Shares of Roblox Corporation (NYSE: RBLX) rose during Wedne...
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024 | Benzinga

REDWOOD CITY, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing ...

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024 | Benzinga

REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing n...

Revolution Medicines to Participate in Upcoming Investor Conferences | Benzinga

REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing t...
Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

REDWOOD CITY, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing t...

Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details | Benzinga

Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compell...

Revolution Medicines Completes Acquisition of EQRx | Benzinga

Acquisition Expected to Add Approximately $1.1 Billion in Net Cash to Revolution Medicines' Balance Sheet, Supporting Late-Stage Development ...
Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition | Benzinga

REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition of EQRx, Inc. | Benzinga

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing t...

Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023 | Benzinga

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing n...
Previous 10 Next 10